Role of toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle
Year: 2013
Type: article
Abstract: Although the cause of Duchenne muscular dystrophy (DMD) is known, the specific factors that initiate and perpetuate disease progression are not well understood. We hypothesized that leaky dystrophin-deficient skeletal muscle releases endogenous danger signals (TLR ligands), which bind to Toll-like receptors (TLRs) on muscle and immune cells and activate downstream processes that facilitate degeneration and regeneration in dystrophic skeletal muscle. Here, we demonstrate that dystrophin-deficient mouse muscle cells show increased expression of several cell-surface and endosomal TLRs. In vitro screening identified ssRNA as a relevant endogenous TLR7 ligand. TLR7 activation led to myd88-dependent production of pro-inflammatory cytokines in dystrophin-deficient muscle cells, and cause significant degeneration/regeneration in vivo in mdx mouse muscle. Also, knockout of the central TLR adaptor protein, myd88 in mdx mice significantly improved skeletal and cardiac muscle function. Likewise, proof-of-concept experiments showed that treating young mdx mice with a TLR7/9 antagonist significantly reduced skeletal muscle inflammation and increased muscle force, suggesting that blocking this pathway may have therapeutic potential for DMD.
Source: Human Molecular Genetics
DOI: 10.1093/hmg/ddt656
Authors: A. Henriques-Pons, Q. Yu, S. Rayavarapu, T. V. Cohen, B. Ampong, H. J. Cha, V. Jahnke, J. Van der Meulen, D. Wang, W. Jiang, E. R. Kandimalla, S. Agrawal, C. F. Spurney, K. Nagaraju
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: National Institutes of Health, Intellectual and Developmental Disabilities Research Center, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Research Resources, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Center for Medical Rehabilitation Research
Awards: G1213387010, Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr, G167242981, Clinical and Translational Science Institute at Children's National, G4366394422, G4731311521, Preclinical drug trial in mouse models of inflammation, G736570329, G8016804368, NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine
OpenAlex ID: W2111712137
